VAXX

Vaxxinity News

Company Name Stock Ticker Symbol Market Type
Vaxxinity Inc VAXX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 1.9% 2.15 09:30:02
Open Price Low Price High Price Close Price Prev Close
2.13 2.13 2.15 2.11
more quote information »

Recent News

Date Time Source Heading
9/13/202208:00GLOBEVaxxinity Announces First Subjects Dosed in Phase 1 Clinical..
9/12/202208:00GLOBEVaxxinity Initiates Rolling Submission for UB-612 COVID-19..
9/08/202216:56EDGARStatement of Changes in Beneficial Ownership (4)
9/01/202208:00GLOBEVaxxinity to Present at Upcoming Investor Conferences in..
8/25/202218:03EDGARStatement of Changes in Beneficial Ownership (4)
8/11/202208:00GLOBEVaxxinity Reports Second Quarter 2022 Financial Results and..
8/04/202207:00GLOBEVaxxinity to Present at the Canaccord Genuity 42nd Annual..
8/02/202208:00GLOBEVaxxinity’s Anti-PCSK9 Candidate Demonstrates Durable LDL..
8/01/202208:00GLOBEVaxxinity Presents Preclinical Data on Tau Vaccine..
7/25/202211:57GLOBEVaxxinity CEO Mei Mei Hu Speaking at White House Summit on..
6/24/202216:49EDGARCurrent Report Filing (8-k)
6/23/202219:55EDGARStatement of Changes in Beneficial Ownership (4)
6/23/202219:50EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
6/23/202219:48EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
6/23/202219:45EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
6/23/202219:43EDGARAmended Statement of Beneficial Ownership (3/a)
6/21/202216:57EDGARStatement of Changes in Beneficial Ownership (4)
6/21/202216:53EDGARStatement of Changes in Beneficial Ownership (4)
6/21/202216:53EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202219:08EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202218:15EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202218:14EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202218:12EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202207:00GLOBEVaxxinity to Participate at the Jefferies Healthcare..
5/09/202207:42GLOBEVaxxinity Reports First Quarter 2022 Financial Results and..
5/06/202206:04EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/05/202213:40EDGARStatement of Changes in Beneficial Ownership (4)
5/05/202207:00GLOBEVaxxinity to Participate at the Bank of America Securities..
5/02/202217:22EDGARProxy Statement (definitive) (def 14a)
5/02/202209:01DJNVaxxinity UB-311 Gets FDA Fast Track Designation for..
5/02/202208:00GLOBEVaxxinity Receives FDA Fast Track Designation for UB-311 for..
4/29/202213:28DJNVaxxinity Shares Rise 55% in Heavy Volume
4/28/202219:26EDGARStatement of Changes in Beneficial Ownership (4)
4/28/202219:20EDGARStatement of Changes in Beneficial Ownership (4)
4/28/202208:00GLOBEVaxxinity Completes Enrollment in Part B of UB-312 Phase 1..
4/27/202217:04EDGARStatement of Ownership (sc 13g)
4/27/202217:03EDGARStatement of Ownership (sc 13g)
4/06/202217:30SEEKCEPI to co-fund Vaxxinity’s phase 3 trial of COVID-19..
4/06/202216:43GLOBECEPI to co-fund Vaxxinity’s pivotal Phase 3 UB-612..
4/04/202219:56EDGARStatement of Changes in Beneficial Ownership (4)
3/28/202210:34SEEKVaxxinity begins dosing in phase 3 trial of COVID-19 vaccine..
3/28/202208:00GLOBEVaxxinity Announces First Participant Dosed in Phase 3 Study..
3/25/202208:35TRMNAnalysts Conflicted on These Healthcare Names: Align Tech..
3/24/202217:26EDGARAnnual Report (10-k)
3/24/202216:59SEEKVaxxinity GAAP EPS of -$0.48
3/24/202216:05GLOBEVaxxinity Reports Fourth Quarter and Full-Year 2021..
3/22/202206:00EDGARCurrent Report Filing (8-k)
3/21/202207:00GLOBEVaxxinity Appoints Dr. Peter Powchik to Board of Directors
2/11/202209:56SEEKVaxxinity says COVID-19 shot had three times stronger..
2/11/202209:28GLOBEVaxxinity’s COVID-19 Vaccine Candidate UB-612 Produces High..


Your Recent History
NASDAQ
VAXX
Vaxxinity
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now